Swiss skincare company Galderma is banking on a drug for eczema treatment to revive sales growth at its pharmaceutical business and help it leave behind a hit from patent expirations.

Galderma is largely known for its leading skincare brand Cetaphil. In 2021, it made its first U.S. buy, purchasing California-based skincare company Alastin and its anti-aging products for an ...

ZUG, Switzerland, January 23, 2025--Galderma will present the latest updates from its innovative aesthetics portfolio at the International Master Course on Aging Science (IMCAS) World Congress ...

Galderma Group AG (SWX:GALD), ... in China.1-7,11-14 This follows Sculptra’s approval by China’s National Medical Products Administration for correcting mid-facial volume loss and/or contour ...

PARIS – L'Oréal is digging deeper into the dermatological products market, taking a 10 percent stake in Galderma, the pure-play dermatology leader and among the largest in injectable aesthetics ...

On Tuesday morning, Galderma launched its Scratch Resistance campaign to highlight one of the most difficult symptoms of atopic dermatitis: nonstop itching. The campaign’s ad spot features atopic ...

The brand benefits from the growing demand for science-based skincare products. In therapeutic dermatology (19% of 2023 net sales), Galderma is a market leader in acne, rosacea, and actinic keratosis.

ZUG, Switzerland, August 05, 2024--Galderma today announced that it has signed a memorandum of understanding with L’Oréal to work towards a new research and development (R&D) collaboration in ...

Galderma is also predicting that consumer interest in products designed to proactively prevent signs of aging will fuel “the use of collagen biostimulators in conjunction with other aesthetic ...

Swiss dermatology company Galderma on Thursday said it generated more than $4 billion in net sales during 2023, up 8.5% on 2022 on a constant currency basis, driven by momentum across its ...

Swiss skincare company Galderma on Thursday said its sales rose by 8.3% on the year to $1.13 billion during the first quarter and signalled confidence about its prospects for the rest of 2025 ...

Galderma launches new ALASTIN Restorative Skin Complex with Next Generation TriHex Technology ... Provide specific products and services to you, such as portfolio management or data aggregation.